About Contact Us Careers
Sign In

Europe OTC Parasiticides Market - Top Companies and Manufacturers

  • Report ID: 4682
  • Published Date: Jan 13, 2023
  • Report Format: PDF, PPT
  1. Europe OTC Parasiticides Market Definition
    1. Market Definition
    2. Segmentation
  2. Assumptions and Other Market Estimation Caveats
  3. Research Methodology
  4. Analyst Review
  5. Executive Summary
  6. Recent Development w.r.t. Parasiticides Market
  7. Summary of the report
  8. European Market Overview
  9. Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Market Trends
    4. Opportunities
  10. Regulatory & Standard Landscape
  11. Industry Risk Analysis
  12. Value Chain Analysis
  13. Strategies Followed by the Market Players
    1. Product development
    2. Mergers & Acquisitions
    3. Joint venture
    4. Product Launch
    5. R&D Investment
  14. Epidemiology Analysis
    1. Prevalence of Zoonotic Disease
    2. Prevalence of Ectoparasites, Endoparasiticides, and Endectocides
  15. Patent Expiry Analysis of Key Drugs in Different Jurisdiction
    1. Formulation Patent
    2. Supplementing Protection Certificates (SPCs)
  16. Sales Analytics of Key Drugs
    1. Seresto
    2. Frontline
    3. Advantage
    4. Others
  17. Rx to OTC Switch Analysis
    1. Present Scenario
    2. Future outlook
  18. Pipeline Analysis of Major Players
  19. Market Opportunity Analysis
  20. Types of Formulation Analysis
    1. Topical
    2. Oral
    3. Injectable
  21. Competitive Landscape
    1. Competitive Positioning
    2. Market Share Analysis, 2021
    3. Company Profiles
      1. Inovet
        1. Detailed Overview
        2. Mergers & Acquisitions
        3. Assessment of Key Product Offerings
        4. Analysis of Growth Strategies
        5. Exhaustive Analysis on Key Financial Indicators
        6. Recent Developments
      2. Merck & Co., Inc.,
      3. Chanelle Pharma
      4. Ceva Sante Animale
      5. Vetoquinol S.A.
      6. Boehringer Ingelheim International GmbH
      7. PetlQ, LLC.
      8. Syndel
      9. Elanco Animal Health Incorporated
  22. Europe OTC Parasiticides Market (Companion Animals)
    1. Market Overview
    2. By Value (USD million)
    3. By Product Type
      1. Ectoparasiticides, 2021-2031F (USD Million)
        1. Pour On, 2021-2031F (USD Million)
        2. Spot On, 2021-2031F (USD Million)
        3. Sprays, 2021-2031F (USD Million)
        4. Others, 2021-2031F (USD Million)
      2. Endoparasiticides, 2021-2031F (USD Million)
        1. Injectable, 2021-2031F (USD Million)
        2. Oral, 2021-2031F (USD Million)
          1. Liquids, 2021-2031F (USD Million)
          2. Tablets, 2021-2031F (USD Million)
          3. Others, 2021-2031F (USD Million)
      3. Endectocides, 2021-2031F (USD Million)
    4. By Animal Type
      1. Dogs, 2021-2031F (USD Million)
      2. Cats, 2021-2031F (USD Million)
      3. Others, 2021-2031F (USD Million)
    5. By End User
      1. Personal user, 2021-2031F (USD Million)
      2. Commercial user, 2021-2031F (USD Million)
    6. By Distribution Channel
      1. Online, 2021-2031F (USD Million)
      2. Offline, 2021-2031F (USD Million) 
  23. By Country
    1. Belgium
      1. By Product Type
        1. Ectoparasiticides, 2021-2031F (USD Million)
          1. Pour On, 2021-2031F (USD Million)
          2. Spot On, 2021-2031F (USD Million)
          3. Sprays, 2021-2031F (USD Million)
          4. Others, 2021-2031F (USD Million)
        2. Endoparasiticides, 2021-2031F (USD Million)
          1. Injectable, 2021-2031F (USD Million)
          2. Oral, 2021-2031F (USD Million)
            1. Liquids, 2021-2031F (USD Million)
            2. Tablets, 2021-2031F (USD Million)
            3. Others, 2021-2031F (USD Million)
        3. Endectocides, 2021-2031F (USD Million)
      2. By Animal Type
        1. Dogs, 2021-2031F (USD Million)
        2. Cats, 2021-2031F (USD Million)
        3. Others, 2021-2031F (USD Million)
      3. By End User
        1. Personal user, 2021-2031F (USD Million)
        2. Commercial user, 2021-2031F (USD Million)
      4. By Distribution Channel
        1. Online, 2021-2031F (USD Million)
        2. Offline, 2021-2031F (USD Million) 
    2. Czech Republic
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    3. France
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    4. Germany
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    5. Greece
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    6. Italy
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    7. Netherlands
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    8. Poland
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    9. Portugal
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    10. Spain
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel
    11. Rest of Europe (EU-27)
      1. By value (USD million)
      2. By Product Type
      3. By Animal Type
      4. By End User
      5. By Distribution Channel

 

Companies Dominating the Europe OTC Parasiticides Landscape

    • Inovet
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck & Co., Inc.
    • Chanelle Pharma
    • Ceva Sante Animale
    • Vetoquinol S.A.
    • Boehringer Ingelheim International GmbH
    • PetlQ, LLC.
    • Syndel
    • Elanco Animal Health Incorporated
Browse Key Market Insights with Data Illustration:

In the News

  • Merck & Co., Inc., announced the acquisition of Vecoxan, the leading brand of parasiticides for ruminant line. Through this acquisition, Merck Animal Health is to improve parasite protection for calves and lambs, expanding its market position.

  • Chanelle Pharma, announced the completion of documentation of new Bisoprolol. For those with heart failure, hypertension, and angina, bisoprolol is regarded as a crucial therapeutic choice.


Author Credits:  Radhika Pawar


  • Report ID: 4682
  • Published Date: Jan 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increased demand for parasiticides, rising empathy for animals, and higher count of livestock are the few factors which is likely to boost the market growth.

The market is anticipated to attain a CAGR of 6.26% over the forecast period, i.e., 2022-2031.

Illegal selling of parasiticides and risk of parasiticides impacting human health and other invertebrates are the few factors that are to hamper the market growth.

The market in rest of Europe is projected to hold the largest market share of USD 180.1 million by the end of 2031 and provide more business opportunities in the future. The market in the region to grow at a CAGR of 5.59% over the forecast period. In 2021, the region garnered a revenue of USD 104.90 million.

The major players in the market are Inovet, Merck & Co., Inc., Chanelle Pharma, Ceva Sante Animale, Vetoquinol S.A., Boehringer Ingelheim International GmbH, PetlQ, LLC., Syndel, Elanco Animal Health Incorporated, and Others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, animal, end user, distribution channel, and by country.

The dog segment is anticipated to garner the largest market size of USD 286.02 million by the end of 2031 and display significant growth opportunities. The segment is to grow at a CAGR of 6.47% over the forecast period. The segment garnered a revenue of USD 153.46 million in 2021.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample